Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Asia 2022 | The EXTREME regimen for head and neck cancer

Avinash Khadela, PhD, L.M. College Of Pharmacy, Ahmedabad, India, explains the EXTREME regimen of cetuximab, cisplatin, and 5-fluorouracil and its role in the treatment of head and neck cancer. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.